...
首页> 外文期刊>Biochemistry and Cell Biology >Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein.
【24h】

Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein.

机译:致癌信号转导子和转录激活子3(STAT3)蛋白的分子破坏。

获取原文
获取原文并翻译 | 示例

摘要

Signal transducer and activator of transcription protein 3 (STAT3) is a latent cytosolic transcription factor that is widely recognized as being a master regulator of the cellular functions that lead to the cancer phenotype. Constitutively activated STAT3 protein activity is routinely observed in human cancers, promoting uncontrolled cell proliferation and suppressing apoptosis. Until relatively recently, inhibition of STAT3 transcriptional activity was achieved indirectly via suppression of upstream kinase activators and extracellular cytokine and (or) growth factor stimuli. However, activated STAT3 forms transcriptionally functional STAT3-STAT3 dimers, providing a valid juncture for targeted downstream molecular inhibition. STAT3's prominent role in cancer has seen a decade of innovative and novel approaches to targeting constitutively active STAT3 protein-protein complexes. This mini-review outlines the progress made towards identifying molecular agents capable of silencing aberrant STAT3 signalling through the disruption of STAT3 complexation events.
机译:信号转导和转录蛋白3(STAT3)的激活剂是一种潜在的胞质转录因子,被广泛认为是导致癌症表型的细胞功能的主要调节因子。在人类癌症中通常观察到组成型激活的STAT3蛋白活性,可促进不受控制的细胞增殖并抑制细胞凋亡。直到最近,STAT3转录活性的抑制是通过抑制上游激酶激活剂和细胞外细胞因子和(或)生长因子刺激间接实现的。然而,激活的STAT3形成转录功能性STAT3-STAT3二聚体,为靶向下游分子抑制提供了有效的结合点。 STAT3在癌症中的重要作用已经见证了十年来针对组成性活性STAT3蛋白-蛋白复合物的创新方法。这份小型综述概述了鉴定能够通过破坏STAT3络合事件而沉默STAT3异常信号传导的分子药物所取得的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号